Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 3 November 2025 - 16:20

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 3 November 2025 - 16:00

Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 30/07/2018, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 3 November 2025 - 15:38

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 30/07/2018, Revision: 15, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More